Click here to get full coverage on How to build a dashboard for DTIL stock - IPO Watch & Target Return Focused Picks - newser.com

How to build a dashboard for DTIL stock - IPO Watch & Target Return Focused Picks  newser.com

How to build a dashboard for DTIL stock - IPO Watch & Target Return Focused Picks - newser.com

Click here to get full coverage on Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance

Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy  Yahoo Finance

Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance

Click here to get full coverage on While Institutions Own 23% of Precision BioSciences, Inc. (NASDAQ:DTIL), Retail Investors Are Its Largest Shareholders With 27% Ownership - 富途牛牛

While Institutions Own 23% of Precision BioSciences, Inc. (NASDAQ:DTIL), Retail Investors Are Its Largest Shareholders With 27% Ownership  富途牛牛

While Institutions Own 23% of Precision BioSciences, Inc. (NASDAQ:DTIL), Retail Investors Are Its Largest Shareholders With 27% Ownership - 富途牛牛

Click here to get full coverage on $DTIL stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

$DTIL stock is down 10% today. Here's what we see in our data.  Quiver Quantitative

$DTIL stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Precision BioSciences Announces $70M Stock Offering - MSN

Precision BioSciences Announces $70M Stock Offering  MSN

Precision BioSciences Announces $70M Stock Offering - MSN

Click here to get full coverage on A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy  simplywall.st

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

Click here to get full coverage on Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - Business Wire

Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025  Business Wire

Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - Business Wire

Click here to get full coverage on How to build a dashboard for DTIL stock - Profit Target & Low Risk High Win Rate Stock Picks - newser.com

How to build a dashboard for DTIL stock - Profit Target & Low Risk High Win Rate Stock Picks  newser.com

How to build a dashboard for DTIL stock - Profit Target & Low Risk High Win Rate Stock Picks - newser.com

Click here to get full coverage on Precision BioSciences (DTIL) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance

Precision BioSciences (DTIL) Moves 11.1% Higher: Will This Strength Last?  Yahoo Finance

Precision BioSciences (DTIL) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on Insider Purchase: Director at $DTIL Buys 2,700 Shares - Quiver Quantitative

Insider Purchase: Director at $DTIL Buys 2,700 Shares  Quiver Quantitative

Insider Purchase: Director at $DTIL Buys 2,700 Shares - Quiver Quantitative

Click here to get full coverage on Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants - Business Wire

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants  Business Wire

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants - Business Wire

Click here to get full coverage on How DTIL stock performs after earnings - Market Movement Recap & Technical Confirmation Alerts - newser.com

How DTIL stock performs after earnings - Market Movement Recap & Technical Confirmation Alerts  newser.com

How DTIL stock performs after earnings - Market Movement Recap & Technical Confirmation Alerts - newser.com

Click here to get full coverage on Why DTIL stock remains resilient - July 2025 Institutional & High Conviction Buy Zone Picks - newser.com

Why DTIL stock remains resilient - July 2025 Institutional & High Conviction Buy Zone Picks  newser.com

Why DTIL stock remains resilient - July 2025 Institutional & High Conviction Buy Zone Picks - newser.com

Click here to get full coverage on Can volume confirm reversal in DTIL - Trade Exit Summary & Verified Entry Point Signals - newser.com

Can volume confirm reversal in DTIL - Trade Exit Summary & Verified Entry Point Signals  newser.com

Can volume confirm reversal in DTIL - Trade Exit Summary & Verified Entry Point Signals - newser.com

Click here to get full coverage on How DTIL stock performs after earnings - 2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com

How DTIL stock performs after earnings - 2025 Fundamental Recap & Safe Swing Trade Setup Alerts  newser.com

How DTIL stock performs after earnings - 2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com

Click here to get full coverage on Has DTIL formed a bullish divergence - Global Markets & Smart Swing Trading Alerts - newser.com

Has DTIL formed a bullish divergence - Global Markets & Smart Swing Trading Alerts  newser.com

Has DTIL formed a bullish divergence - Global Markets & Smart Swing Trading Alerts - newser.com

Click here to get full coverage on Can volume confirm reversal in DTIL - Portfolio Risk Summary & Daily Stock Trend Watchlist - newser.com

Can volume confirm reversal in DTIL - Portfolio Risk Summary & Daily Stock Trend Watchlist  newser.com

Can volume confirm reversal in DTIL - Portfolio Risk Summary & Daily Stock Trend Watchlist - newser.com

Click here to get full coverage on Will DTIL stock keep outperforming rivals - July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com

Will DTIL stock keep outperforming rivals - July 2025 Weekly Recap & Fast Entry and Exit Trade Plans  newser.com

Will DTIL stock keep outperforming rivals - July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com

Click here to get full coverage on DTIL’s volatility index tracking explained - Quarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com

DTIL’s volatility index tracking explained - Quarterly Risk Review & Real-Time Chart Pattern Alerts  newser.com

DTIL’s volatility index tracking explained - Quarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com

Click here to get full coverage on Is DTIL building a consolidation base - July 2025 News Drivers & AI Powered Buy and Sell Recommendations - newser.com

Is DTIL building a consolidation base - July 2025 News Drivers & AI Powered Buy and Sell Recommendations  newser.com

Is DTIL building a consolidation base - July 2025 News Drivers & AI Powered Buy and Sell Recommendations - newser.com

Click here to get full coverage on Why DTIL stock remains resilient - Weekly Trade Summary & Daily Volume Surge Signals - newser.com

Why DTIL stock remains resilient - Weekly Trade Summary & Daily Volume Surge Signals  newser.com

Why DTIL stock remains resilient - Weekly Trade Summary & Daily Volume Surge Signals - newser.com

Click here to get full coverage on Has DTIL formed a bullish divergence - CEO Change & Stock Market Timing Techniques - newser.com

Has DTIL formed a bullish divergence - CEO Change & Stock Market Timing Techniques  newser.com

Has DTIL formed a bullish divergence - CEO Change & Stock Market Timing Techniques - newser.com

Click here to get full coverage on Precision BioSciences: Q3 Earnings Snapshot - WRAL

Precision BioSciences: Q3 Earnings Snapshot  WRAL

Precision BioSciences: Q3 Earnings Snapshot - WRAL

Click here to get full coverage on Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Will DTIL stock deliver shareholder value - Analyst Upgrade & Scalable Portfolio Growth Methods - newser.com

Will DTIL stock deliver shareholder value - Analyst Upgrade & Scalable Portfolio Growth Methods  newser.com

Will DTIL stock deliver shareholder value - Analyst Upgrade & Scalable Portfolio Growth Methods - newser.com

Click here to get full coverage on Is DTIL stock reversal real or fake - 2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com

Is DTIL stock reversal real or fake - 2025 EndofYear Setup & Long Hold Capital Preservation Tips  newser.com

Is DTIL stock reversal real or fake - 2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com

Click here to get full coverage on Brown Melinda buys $6846 in Precision BioSciences (DTIL) - Investing.com

Brown Melinda buys $6846 in Precision BioSciences (DTIL)  Investing.com

Brown Melinda buys $6846 in Precision BioSciences (DTIL) - Investing.com

Click here to get full coverage on How DTIL stock performs after earnings - 2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com

How DTIL stock performs after earnings - 2025 Volatility Report & Weekly High Conviction Trade Ideas  newser.com

How DTIL stock performs after earnings - 2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com

Click here to get full coverage on Precision BioSciences (DTIL) Launches $75 Million Stock and Warr - GuruFocus

Precision BioSciences (DTIL) Launches $75 Million Stock and Warr  GuruFocus

Precision BioSciences (DTIL) Launches $75 Million Stock and Warr - GuruFocus

Click here to get full coverage on Precision BioSciences (DTIL) Announces $75 Million Stock Offerin - GuruFocus

Precision BioSciences (DTIL) Announces $75 Million Stock Offerin  GuruFocus

Precision BioSciences (DTIL) Announces $75 Million Stock Offerin - GuruFocus

Click here to get full coverage on DTIL Stock: Surge or Bubble? - StocksToTrade

DTIL Stock: Surge or Bubble?  StocksToTrade

DTIL Stock: Surge or Bubble? - StocksToTrade

Click here to get full coverage on Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus

Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations  GuruFocus

Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus

Click here to get full coverage on Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6 - Business Wire

Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6  Business Wire

Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6 - Business Wire

Click here to get full coverage on Precision Bio (NASDAQ: DTIL) shows HBV DNA editing in Phase 1; 66% HBsAg drop, no DLTs - Stock Titan

Precision Bio (NASDAQ: DTIL) shows HBV DNA editing in Phase 1; 66% HBsAg drop, no DLTs  Stock Titan

Precision Bio (NASDAQ: DTIL) shows HBV DNA editing in Phase 1; 66% HBsAg drop, no DLTs - Stock Titan

Click here to get full coverage on Precision BioSciences Announces Stock Offering and Warrants - TradingView

Precision BioSciences Announces Stock Offering and Warrants  TradingView

Precision BioSciences Announces Stock Offering and Warrants - TradingView

Click here to get full coverage on Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update  Business Wire

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire

Click here to get full coverage on Precision BioSciences (DTIL) Reveals Key Findings from Hepatitis B Study - GuruFocus

Precision BioSciences (DTIL) Reveals Key Findings from Hepatitis B Study  GuruFocus

Precision BioSciences (DTIL) Reveals Key Findings from Hepatitis B Study - GuruFocus

Click here to get full coverage on DTIL Stock Surge: Analyzing Recent Developments - timothysykes.com

DTIL Stock Surge: Analyzing Recent Developments  timothysykes.com

DTIL Stock Surge: Analyzing Recent Developments - timothysykes.com

Click here to get full coverage on Precision BioSciences (DTIL) Showcases Genomic Advances with ARC - GuruFocus

Precision BioSciences (DTIL) Showcases Genomic Advances with ARC  GuruFocus

Precision BioSciences (DTIL) Showcases Genomic Advances with ARC - GuruFocus

Click here to get full coverage on Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status - Business Wire

Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status  Business Wire

Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status - Business Wire

Click here to get full coverage on Custom strategy builders for tracking DTIL - 2025 Dividend Review & Verified Entry Point Signals - newser.com

Custom strategy builders for tracking DTIL - 2025 Dividend Review & Verified Entry Point Signals  newser.com

Custom strategy builders for tracking DTIL - 2025 Dividend Review & Verified Entry Point Signals - newser.com

Click here to get full coverage on What’s the recovery path for long term holders of DTIL - July 2025 Fed Impact & Real-Time Market Trend Scan - newser.com

What’s the recovery path for long term holders of DTIL - July 2025 Fed Impact & Real-Time Market Trend Scan  newser.com

What’s the recovery path for long term holders of DTIL - July 2025 Fed Impact & Real-Time Market Trend Scan - newser.com

Click here to get full coverage on Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - Business Wire

Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial  Business Wire

Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - Business Wire

Click here to get full coverage on DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up - Yahoo Finance

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up  Yahoo Finance

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up - Yahoo Finance

Click here to get full coverage on Precision BioSciences Announces $70M Stock Offering - TipRanks

Precision BioSciences Announces $70M Stock Offering  TipRanks

Precision BioSciences Announces $70M Stock Offering - TipRanks

Click here to get full coverage on Will DTIL stock deliver shareholder value - July 2025 Big Picture & High Return Stock Watch Alerts - newser.com

Will DTIL stock deliver shareholder value - July 2025 Big Picture & High Return Stock Watch Alerts  newser.com

Will DTIL stock deliver shareholder value - July 2025 Big Picture & High Return Stock Watch Alerts - newser.com

Click here to get full coverage on PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society - Yahoo Finance

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society  Yahoo Finance

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society - Yahoo Finance

Click here to get full coverage on Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy  Business Wire

Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Click here to get full coverage on Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire

Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update  Business Wire

Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire

Click here to get full coverage on Precision BioSciences Q3 revenue falls sharply - TradingView

Precision BioSciences Q3 revenue falls sharply  TradingView

Precision BioSciences Q3 revenue falls sharply - TradingView

Click here to get full coverage on Precision BioSciences Unveils Promising ELIMINATE-B Trial Results - MSN

Precision BioSciences Unveils Promising ELIMINATE-B Trial Results  MSN

Precision BioSciences Unveils Promising ELIMINATE-B Trial Results - MSN

Click here to get full coverage on Precision BioSciences Inc Updates on ELIMINATE-B Clinical Trial - TradingView

Precision BioSciences Inc Updates on ELIMINATE-B Clinical Trial  TradingView

Precision BioSciences Inc Updates on ELIMINATE-B Clinical Trial - TradingView

Click here to get full coverage on Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic - Business Wire

Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic  Business Wire

Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic - Business Wire

Click here to get full coverage on Precision BioSciences launches $75M stock and warrant offering - MSN

Precision BioSciences launches $75M stock and warrant offering  MSN

Precision BioSciences launches $75M stock and warrant offering - MSN

Click here to get full coverage on Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL)  Seeking Alpha

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView

PRECISION BIOSCIENCES INC SEC 10-Q Report  TradingView

PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView

Click here to get full coverage on Precision BioSciences gets FDA rare disease status for DMD treatment, stock jumps 10% - Seeking Alpha

Precision BioSciences gets FDA rare disease status for DMD treatment, stock jumps 10%  Seeking Alpha

Precision BioSciences gets FDA rare disease status for DMD treatment, stock jumps 10% - Seeking Alpha

Click here to get full coverage on Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B - Business Wire

Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B  Business Wire

Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B - Business Wire

Click here to get full coverage on Precision BioSciences Unveils Promising ELIMINATE-B Trial Results - TipRanks

Precision BioSciences Unveils Promising ELIMINATE-B Trial Results  TipRanks

Precision BioSciences Unveils Promising ELIMINATE-B Trial Results - TipRanks

Click here to get full coverage on Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants - Legal Desire Media and Insights

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants  Legal Desire Media and Insights

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants - Legal Desire Media and Insights

Click here to get full coverage on Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants - 01net

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants  01net

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants - 01net

Click here to get full coverage on Precision BioSciences raises $75 million in stock and warrant offering By Investing.com - Investing.com South Africa

Precision BioSciences raises $75 million in stock and warrant offering By Investing.com  Investing.com South Africa

Precision BioSciences raises $75 million in stock and warrant offering By Investing.com - Investing.com South Africa

Click here to get full coverage on Despite Fast-paced Momentum, Precision BioSciences (DTIL) Is Still a Bargain Stock - Yahoo Finance

Despite Fast-paced Momentum, Precision BioSciences (DTIL) Is Still a Bargain Stock  Yahoo Finance

Despite Fast-paced Momentum, Precision BioSciences (DTIL) Is Still a Bargain Stock - Yahoo Finance

Click here to get full coverage on Wall Street Analysts Think Precision BioSciences (DTIL) Could Surge 277.6%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think Precision BioSciences (DTIL) Could Surge 277.6%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think Precision BioSciences (DTIL) Could Surge 277.6%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Durham biotech trims staff to extend cash ruwnay - The Business Journals

Durham biotech trims staff to extend cash ruwnay  The Business Journals

Durham biotech trims staff to extend cash ruwnay - The Business Journals

Click here to get full coverage on Dhunseri Tea & Industries Receives Credit Rating Reaffirmation from CARE Ratings - scanx.trade

Dhunseri Tea & Industries Receives Credit Rating Reaffirmation from CARE Ratings  scanx.trade

DTIL

Price Chart

Key Statistics

Technicals

About DTIL

Latest News

How to build a dashboard for DTIL stock - IPO Watch & Target Return Focused Picks - newser.com

Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance

While Institutions Own 23% of Precision BioSciences, Inc. (NASDAQ:DTIL), Retail Investors Are Its Largest Shareholders With 27% Ownership - 富途牛牛

Advanced Charts

Top Gainers

Top Losers